Search

everythinglearnresearchcommunity

for

Search:↓

Pegylated interferon-alpha 2a can cause a rare nerve disorder, but early treatment can lead to full recovery.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

AcD scaffolds improve tissue repair and regeneration by combining stem cells with a supportive matrix.

Targeted photodynamic therapy is a promising method for precise disease treatment and diagnosis.

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

An antibiotic called co-trimoxazole can effectively treat autoimmune diseases.

ALRN-6924 may prevent hair loss caused by chemotherapy.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

ALRN-6924 can protect hair follicles from chemotherapy damage by temporarily stopping cell division.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Upadacitinib may effectively treat resistant lichen planopilaris.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

The research developed new fortilin protein constructs for potential heart disease treatments.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

Tph cells are linked to the severity of systemic lupus erythematosus.